BioVie Inc. Other Liabilities
BioVie Inc. (BIVI) had Other Liabilities of $48.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:OtherLiabilities · last filed 2024-05-14
- 2024-03-31: Other Liabilities $48.00K.
- 2023-12-31: Other Liabilities $48.00K.
- 2023-09-30: Other Liabilities $48.00K.
- 2023-06-30: Other Liabilities $48.40K.
| Period end | Other Liabilities |
|---|---|
| 2024-03-31 | $48.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $48.00K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $48.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $48.40K 10-K · filed 2023-08-16 |
| 2023-03-31 | $193.54K 10-Q · filed 2023-05-12 |
| 2022-06-30 | $1.30M 10-K · filed 2023-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |